Download details
Neurocrine Biosciences Announces Positive Data from NBI Phase III Trial in Tardive Dyskinesia
Created
Monday, 12 December 2016 22:15
Changed
Monday, 12 December 2016 22:15
Size
155.99 KB
Rating
Created by
Jim Davis
Downloads
431